Stacks and mixtures
Glow / KLOW
Editorial audit: October 15, 2026 · draft; scientific, medical and translation review pending
01What is reported
Glow and KLOW are names for reported multicomponent mixtures involving BPC-157, TB-500-related material, GHK-Cu and sometimes KPV. Names do not fix the composition.
02Proposed rationale
Sources combine skin, repair and inflammation aims. The combined rationale is a hypothesis about the mixture, not evidence of a measured combined effect.
03What the research shows
Evidence for ingredients is heterogeneous and does not automatically establish the exact mixture’s efficacy, stability or safety.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
04Limits and unknowns
Total mass per vial is not a per-application dose. In a fixed mixture, changing the withdrawn volume changes every component’s quantity together.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
05Questions to ask about the product
Are all component masses and identities declared, and are compatibility/stability claims supported for that exact formulation?
06Open research question
How often are fixed-mixture proportions documented well enough to interpret exposure, and which fields are most often missing?
Primary and regulatory references
- 1.
- 2.
- 3.